Sign in
Taking people in NetherlandsPhase 1/2

Fentanyl vaccine study for opioid-induced slowed breathing

Tests a fentanyl vaccine in adults, looking at opioid-induced respiratory depression.

Key facts

Who runs it
ARMR Sciences Inc.
Where
Leiden, NetherlandsSee the site
Registry title
A Phase 1 Study of Fentanyl Vaccine
Status
Recruiting
Phase
Phase 1/2
People taking part
130 people, planned
Started
26 Feb 2026
Expected to end
30 Jun 2027
Type of study
Interventional
Record updated
20 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 18 to 64 for a Phase 1 study of a fentanyl vaccine. The record does not list further criteria.

Age
18 to 64 years
Sex
All sexes can join

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 64 years old?

Where in Netherlands

  • Centre for Human Drug ResearchLeiden, NetherlandsTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Plain-language title
Fentanyl vaccine study for opioid-induced slowed breathingGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 9 November 2026.
Fit questions
Built from 2025-524277-16-00, who can take part
Record updated
20 October 2026